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Can the Spitzer Quality of Life Index help to reduce prognostic
uncertainty in terminal care?
J.M. Addington-Hall, L.D. MacDonald & H.R. Anderson
Department ofPublic Health Sciences, St George's Hospital Medical School, Cranmer Terrace, London SW17 ORE, UK.
Summary Data from an on-going trial of co-ordinating care for terminally ill cancer patients are used to
investigate whether the Spitzer Quality of Life (QL) Index can be used to reduce prognostic uncertainty in
terminal care. Four questions are addressed. First, can doctors and nurses distinguish between patients with a
prognosis of more or less than 1 year? Second, do the medical and nursing staff differ in their ability to
estimate prognosis? Third, are there differences in the length of life remaining between groups of patients with
different QL Index scores? Fourth, how well does the QL Index predict the likelihood of individual patients
dying within 6 months of assessment? Doctors and nurses assigned between 17 and 25% of patients to the
wrong prognostic group and were as likely to over-estimate as to under-estimate life expectancy. Medical and
nursing staff did not differ in their ability to make prognostic judgements. Patients with a low QL Index score
were more likely to die within 6 months than those with higher scores, but scores on the Index were not strong
predictors of 6-month survival in individual patients. The Index is not accurate enough to be used to predict
what sort of treatment terminally ill patients will require in the future and for how long. Nevertheless, it may
prove valuable for those planning services for terminally ill cancer patients who require information on the
levels of need in a population.
Accurate estimates of the length of life remaining to cancer
patients are needed for a number of reasons:
1. To enable clinicians to advise patients and families and
to plan care so that patients can have a dignified and com-
fortable death.
2. It is difficult to estimate accurately the need for services
for terminally ill cancer patients from routine cancer statistics
such as 5-year survival rates for specified cancer sites, not
least because some patients are only registered as having
cancer after death. Information on the current use of services
can also give an inaccurate impression of need for services as
some patients do not receive appropriate services due to, for
instance, regional variations in the availability of specialist
services (Lunt & Hillier, 1981) and to the fact that some
patients are not referred to services which are available and
may have been beneficial to them (Barnett & McCarthy,
1987). Those planning services for terminally ill cancer
patients would benefit from reliable information on the prog-
nosis of patients currently being treated for cancer as this
could help them estimate the number of patients likely to
need terminal care services in the near future.
3. Such information can help to ensure that specialist ter-
minal care resources are allocated to patients who need them
most. This is particularly important in the USA where doc-
tors have to certify that patients have a life expectancy of 6
months or under for them to qualify for Medicare reimburse-
ment of the costs of hospice care (Forster & Lynn, 1988).
Errors in estimating prognosis lead to patients who would
benefit from hospice care being excluded or to expensive and
scarce resources being given to patients who have a longer
length of life remaining (Pearlman, 1988).
Doctors and nurses are reported to be over-optimistic in
their predictions of the length of life remaining to terminally
ill cancer patients (Evans & McCarthy, 1985; Forster &
Lynn, 1988; Parkes, 1972). Ways of complementing the esti-
mates of medical and nursing staff have therefore been
sought. There has been interest in using performance status
and quality of life measures to aid prognosis. The Karnofsky
Index, which is often used by clinicians to assess performance
status (Clark & Fallowfield, 1986), has been shown to have a
weak but positive relationship with the length of life remain-
ing (Evans & McCarthy, 1985; Mor et al., 1984; Yates et al.,
1980). However, the Index has been criticised because it is
rated by clinicians, rather than patients, and large discrepan-
cies have been reported between assessments made by clinic-
ians and patient assessments of quality of life (Padilla et al.,
1983). In addition, low reliability coefficients have been
reported (Yates et al., 1980). The Karnofsky Index may not,
therefore, be suitable for widespread use as a tool for reduc-
ing prognostic uncertainty in terminal care.
The QL (Quality of Life) Index devised by Spitzer and his
colleagues (1981) has been recommended to clinicians as a
short, easily rated measure of quality of life (Clark & Fallow-
field, 1986). It differs from performance status measures in
that it also measures aspects of quality of life such as social
support and outlook, although scores on it have been shown
to be determined mainly by aspects of performance status,
such as ability to perform activities of daily living, activity
levels and health (Slevin et al., 1988; Mor, 1987). In contrast
to the Karnofsky Index, it can be rated by both clinicians
and patients and good correlations have been found between
assessments made by clinicians and self-assessments (Spitzer
et al., 1981). High inter-rater reliability coefficients and good
levels of test-retest agreement have also been reported
(Spitzer et al., 1981; Slevin et al., 1988). Data from the
National Hospice Study have shown that mean scores of
cancer patients on the QL Index decline as death approaches
(Morris et al., 1986; Morris & Sherwood, 1987). This indi-
cates that the Index may be useful in reducing prognostic
uncertainty in terminal care.
Data from an on-going randomised controlled trial of the
effects of the co-ordination of services for terminally ill
cancer patients (MacDonald, 1989) are used to examine these
issues further. Four questions are investigated. First, are
doctors and nurses able to distinguish between cancer
patients with a prognosis of more or less than 1 year?
Second, do medical and nursing staff differ in their ability to
estimate prognosis? Third, are there differences in the length
of life remaining between groups of patients with different
QL Index scores? Fourth, how well does the QL Index
predict the likelihood of individual cancer patients dying
within 6 months of assessment?
Methods
All patients admitted to hospitals in Wandsworth (an inner
London health district) with a diagnosis of cancer were
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notified to the study team, as were patients attending selected
outpatient clinics (oncology, general surgery, urology and
chest clinics). Doctors and nurses were asked to predict
whether they expected the patient to live for more or less
than 1 year. They were assured that this information would
not be divulged to the patient and were reminded that an
overly pessimistic prognosis would have no adverse conse-
quences for the patient. If they were unsure as to which
category was appropriate for a patient they were encouraged
to be pessimistic. Patients with a predicted life expectancy of
less than 1 year were eligible for the trial.
Patients entering the trial were interviewed at home shortly
after discharge from hospital or the outpatient visit at which
they were notified, as appropriate, in order to assess pain and
symptom control, levels of anxiety and depression, ability to
perform activities of daily living, satisfaction with services
and family well-being. The QL Index was included as a
summary measure of quality of life and to give some indica-
tion of the likely length of life remaining to the patients.
Patients were asked the health question from the QL Index
during the interview. The remaining items on the Index were
scored by the interviewer after the interview.
In order to investigate the accuracy of the doctors' and
nurses' predictions of life remaining two survival curves were
calculated using life table methodology, first for all patients
with a life expectancy of more than a year and secondly for
all those with one of under a year.
The data were then sub-divided according to whether the
estimate of prognosis was made by a doctor or by a member
of the nursing staff. Survival curves were again calculated
separately for patients with a life expectancy of more than a
year and those with one of under a year. The log rank test
(Peto et al., 1977) was then used, first to compare the sur-
vival curve for patients given a prognosis of over I year by
medical staff with that for patients given a similar prognosis
by nursing staff, and secondly to compare the survival curves
for patients given a prognosis of under 1 year by members of
the two professions.
Differences in length of life remaining to groups of patients
with different QL Index scores at interview were examined
using survival curves, again calculated using life table
methodology.
To investigate whether the QL Index can be used to
predict the likelihood of individual cancer patients dying
within 6 months of assessment all possible cut-off points on
the Index were used to predict the likelihood of patients with
scores above or below the cut-off dying within this period.
The positive and negative predictive values, specificity and
sensitivity of each cut-off were calculated. (Six months was
chosen as the period for this investigation because patients
with a prognosis of less than this are eligible for reimburse-
ment of hospice costs in the USA while those with a longer
prognosis are not. There is, therefore, a need to be able to
determine accurately the likelihood of individual cancer
patients dying within 6 months of assessment.)
Results
Were doctors and nurses able to distinguish between cancer
patients with a prognosis ofmore or less thanI year?
In total, 659 patients with a predicted life expectancy of more
than 1 year and 469 with a predicted life expectancy of less
than 1 year were notified to the trial from 38 hospital wards
and 12 outpatient clinics during the first 2 years of the trial
(1 April 1987 to 31 March 1989). Survival curves are pre-
sented in Figure 1.
Six-month survival in patients with a predicted life expec-
tancy of over 1 year was 90% (95% confidence intervals
87-93%) while 1-year survival was 85% (95% confidence
intervals 82-89%). Six-month survival of patients with a
predicted life expectancy of under 1 year was 45% (95%
confidence intervals 40-49%) while 1-year survival was 31%
(95% confidence intervals 26-36%).
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Figure 1 Survival curves for cancer patients given a prognosis of
over 1 year and under 1 year.
These results show that medical and nursing staff over-
estimated 1-year survival in 11-18% of patients given a
prognosis of over 1 year, and under-estimated survival in
26-36% of those given a prognosis of under 1 year. Overall,
survival was over-estimated in 12% and under-estimated in
9% of the total sample of 1,128 patients.
Did medical and nursing staffdiffer in their ability to estimate
prognosis?
Medical staff gave 227 patients a prognosis of over 1 year
and 92 patients a prognosis of under a year. One hundred
and fifty-five estimates of prognosis were made by consult-
ants, 58 by senior registrars, 43 by registrars, 42 by house
officers and 21 by doctors whose position was unknown.
Nursing staff gave 428 patients a prognosis of over 1 year
and 376 one of under a year. Ward sisters or charge nurses
made 318 prognostic estimates, staff nurses made 409 and 77
were made by unspecified members of the nursing staff. Of
the 279 forms returned from outpatient clinics 93% were
completed by medical staff, compared to 7% of the 844
forms received from hospital wards.
Six-month survival in patients given a prognosis of over 1
year by medical staff was 90% (95% confidence intervals
86-95%) while 1-year survival was 83% (95% confidence
intervals 76-89%). Ninety per cent of patients given a prog-
nosis of over 1 year by nursing staff survived for 6 months
(95% confidence intervals 87-93%) and 86% survived for 1
year (95% confidence intervals 82-90%).
Six-months survival in patients given a prognosis of under
year by medical staff was 54% (95% confidence intervals
43-64%) while 31% survived for 1 year (95% confidence
intervals 19-43%). Forty-three per cent of patients given this
prognosis by nursing staff survived for 6 months (95% con-
fidence intervals 37-48%) and 1 year survival was 32%
(95% confidence intervals 26-37%). These figures suggest
that 6-month survival was lower in patients given this prog-
nosis by nurses than it was in those given it by doctors, but
that a similar proportion survived for more than a year.
The survival curve for patients given a prognosis of over
year by medical staff was not significantly different from
that for patients given a similar prognosis by nursing staff
(Figure 2: doctors, observed deaths= 31, expected = 27;
nurses, observed deaths = 53, expected= 56.6; X2 = 0.82, d.f.
1, P>0.05). The same was true for patients given a prog-
nosis of under 1 year (Figure 2: doctors, observed
deaths = 59, expected = 65.9; nurses, observed deaths = 239,
expected = 232; x2 = 0.92, d.f. 1, P>0.05). These results
indicate that the medical and nursing staff did not differ in
their ability to estimate whether patients would live for more
than or less than 1 year.
Are there diferences in the length oflife remaining between
groups ofpatients with different QL Index scores?
Out of the 469 patients with a predicted life expectancy of
less than 1 year, 230 were interviewed, 130 died before inter-
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Figure 2 Survival curves for patients given prognosis of over a
year and under a year by nursing and medical staff. --- Nurses
<year; Nurses>year; ----- Doctors<year; ,.... Doctors
> year.
view, 27 declined to be interviewed, 34 were discharged to an
institution, 19 moved out of the area and 28 awaited inter-
view. Table I shows the age and sex distribution and the site
of the cancer of interviewed patients. Survival curves were
calculated for different QL Index scores obtained from inter-
views with these patients (Figure 3). Six and 12-month sur-
vival rates for groups of patients with different QL Index
scores are given in Table II. These results show that patients
with low QL Index scores died sooner than those with higher
scores. It can be seen from the figures for 6-month survival
that 11% of those with scores of nine or ten died within 6
months compared with at least 65% of those with scores of
four or less. In terms of 12-month survival 54% of those with
the highest scores died within this period compared with at
least 78% of those with the lowest scores.
Table I Age, sex and site of cancer of patients notified to trial of
co-ordinating care for terminally ill cancer patients with a life
expectancy of under 1 year
n (%)
Age groupa (years)
18-34 4 (2%)
35-49 9 (4%)
50-64 40(17%)
65-74 65 (28%)
>--75 111(48%)
Sex
Male 118 (51%)
Female 112 (49%)
Site ofprimar/
Lung 57 (25%)
Colorectal 41 (18%)
Breast 32 (14%)
Prostate 22 (10%)
Other 76 (34%)
'Unknown for one subject. bUnknown for two subjects.
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Figure 3 Survival curves for patients with differing Spitzer QL
Index scores. QL 9, 10; - - QL 8; ,.... QL 7; QL 6;
-- QL .5; .....QL4; QLs 1,2,3.
Table II Six and 12-month survival ratesa for patients with varying
Spitzer QL Index scores at interview
Six-month survival Twelve-month survival
Spitzer QL (95% confidence (95% confidence
Index score n interval) % interval) %
1, 2, 3 18 34( 9-58) 17 (-10-44)
4 33 35 (18-52) 22 ( 6-38)
5 44 65 (49-81) 56( 40-72)
6 41 53 (37-70) 40 ( 23-57)
7 42 56 (40-73) 36( 18-55)
8 35 76 (62-90) 58 ( 40-76)
9, 10 18 89(74-104) 46( 21-70)
aCalculated using life table methodology.
How well can the QL Indexpredict the likelihood ofindividual
cancerpatients dying within 6 months ofassessment?
All possible cut-off points on the QL Index were used to
predict the likelihood of patients with scores above or below
the cut-off dying within 6 months of interview. Table III
gives the positive and negative predictive values together with
the sensitivity and specificity rates associated with each cut-
off.
Positive predictive values (that is the proportion ofpatients
with scores at or below cut-off who died within 6 months)
improved as the cut-off point on the QL Index decreased. In
contrast negative predictive values (the proportion ofpatients
with scores above cut-off who survived for longer than 6
months) declined as the cut-off point was lowered. For ex-
ample, 73% of those with a QL Index score of three or less
died within 6 months while 60% of those with a score of
more than three lived for longer than this. In contrast 43%
of those with scores of eight or less died within 6 months
while 88% of those with scores of nine or ten lived for
longer.
As the cut-off on the QL Index was raised the sensitivity of
the test (the proportion of all patients dying within 6 months
Table III Accuracy ofthe SpitzerQL Index inpredictingdeath within
6 months ofinterview: positive and negative predictive values and rates
ofsensitivityandspecificityassociatedwithusingdifferentcut-offpoints
on the Index to distinguish patients likely to die within 6 months from
those who will live longer
Predictive values
Cut-offpoint (%) Sensitivity Specificity
on Spitzer QL Index Positive Negative (%) (%)
2 or less 75 60 4 99
versus
3 or more
3 or less 73 62 11 97
versus
4 or more
4 or less 64 65 31 88
versus
5 or more
5 or less 48 65 45 67
versus
6 or more
6 or less 48 70 67 51
versus
7 or more
7 or less 47 79 86 35
versus
8 or more
8 or less 43 88 97 14
versus
9 or more
9 or less 42 100 100 6
versus
10
n = 181, total deaths in 6 months = 73. Patientswere included in this
analysisonlyif6monthshadelapsed betweeninterviewandthepointof
analysis (2 years after the beginning of the trial).
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who had scores at or below cut-off) improved. The specificity
(the proportion of all patients surviving 6 months who had
scores above cut-off) was, however, reduced. A cut-off of
three included 11% of all patients who died within 6 months
while 97% of those who lived for longer had scores of more
than three. In contrast a cut-off of eight included 97% of
those who died within 6 months while 14% of those who
lived for longer had scores greater than eight: 86% of those
who did not die in 6 months were therefore inappropriately
assigned to the 'dead in 6 months' group. Good sensitivity
was therefore obtained at the cost of including a high pro-
portion of patients who did not die within 6 months.
Discussion
The first question addressed in this paper was how well
doctors and nurses were able to distinguish between cancer
patients with a life expectancy of more or less than 1 year.
Results showed that errors were made in between 17 and
25% of cases. This suggests the need to search for other
estimates of prognosis to complement clinical judgement.
Previous studies have shown that doctors and nurses tend
to be overly optimistic when estimating life expectancy (For-
ster & Lynn, 1988; Parkes, 1972; Evans & McCarthy, 1985).
Results of the present study suggest that staff are no more
likely to over-estimate than to under-estimate life expectancy
in cancer patients. The contrast between these results and
those of other studies may be because the latter were con-
cerned with estimating the precise length of life remaining to
patients already predicted to have a limited prognosis, such
as patients referred to a terminal care support team (Evans &
McCarthy, 1985). In contrast, patients in the present study
were drawn from the general population of cancer patients in
contact with a district general hospital.
Although estimates of life expectancy in this study were
inaccurate in approximately 23% of all patients, the propor-
tion who were given a prognosis of less than 1 year corre-
sponded closely to the proportion who died within a year
(41% versus 38%). This has important implications for the
planning of services for the terminally ill. If Wandsworth
Health Authority had used the judgements of prognosis
made by the medical and nursing staff to estimate the need
for such services they would have found the demand for
these services to be very close to the estimate. Such estimates
may, therefore, be sufficiently accurate to be of use to those
planning services despite the fact that they are inaccurate for
approximately one in five individual cancer patients.
The second question was whether medical and nursing staff
differed in their ability to estimate the prognosis of cancer
patients. The results showed that there were no significant
differences in the length of survival of patients given a prog-
nosis of over 1 year by doctors and that of those given a
similar prognosis by nurses. The same was true for patients
given a prognosis of under 1 year. The doctors and nurses
who took part in this study did not, therefore, appear to
differ in their ability to estimate the prognosis of patients.
However, it should be noted that doctors mainly estimated
the prognosis of patients attending outpatient clinics, while
most of prognostic estimates made by nursing staff were for
inpatients. The information available to staff during a brief
contact with a patient in an outpatient clinic may differ in
both kind and depth to that available to staff who care for a
patient during an inpatient stay. The medical and nursing
staff in this study may therefore have had different types and
amounts of information available to them. In addition, the
outpatients were likely to be less severely ill at the time of
assessment than inpatients. This means that the medical and
nursing staff did not make estimates of prognosis for truly
comparable groups of patients. Evidence for this comes from
the fact that, although 12-month survival rates were very
similar in the two groups, more patients given a prognosis of
under 1 year by nursing staff than by medical staff died
within 6 months, indicating that this group contained more
severely ill patients. Caution is therefore needed in inter-
preting these results: differences in the ability of medical and
nursing staff to make estimates of prognosis may have
emerged if these estimates had been made for comparable
groups of patients and if the same sources of information
had been available to both doctors and nurses.
The third question was whether there were differences in
the length of life remaining when groups of patients with
different QL Index scores were compared. Although too
much emphasis should not be placed on the results because
of large confidence intervals, results suggest that patients
with low QL Index scores were more likely to die within 6
months of interview than those with high scores. This is
consistent with the results of the National Hospice Study
(Morris et al., 1986; Morris & Sherwood, 1987) which found
that groups of patients close to death had lower mean QL
Index scores than those who survived longer. These results
suggest that the QL Index may be useful in reducing prog-
nostic uncertainty in terminal care. This possibility was ex-
plored by investigating whether scores on the QL Index
could be used to predict the likelihood of cancer patients
dying within 6 months of assessment. It was found that the
QL Index was not a strong predictor of this in individual
patients. It may concluded that by itself the QL Index is not
sufficiently accurate to be used when making important
decisions about treatment and care. It might, however, make
a valuable contribution to the decision-making process when
combined with other information already available to
clinicians.
Evidence from previous studies suggest that knowledge of
the patient's sex, age, primary tumour type or site of meta-
stases may contribute little to the prediction of survival times
(Reuben et al., 1988) and that the same is true for psycho-
logical factors such as feelings of hopelessness, life satisfac-
tion and the amount of adjustment needed in response to
initial diagnosis (Cassileth et al., 1988). Instead, it has been
suggested that clinical features such as performance status
and the presence of certain symptoms may give a better idea
of prognosis (Cassileth et al., 1988; Reuben et al., 1988). For
instance, Reuben et al. (1988) found that the predictive
power of the Karnofsky Index was improved when combined
with five symptoms (shortness of breath, problems eating or
loss of appetite, trouble swallowing, dry mouth and weight
loss) which had independent predictive value. They suggest
that these symptoms are indicative of a 'terminal cancer
syndrome' which spans across tumour type and metastases
sites. The predictive value of the QL Index may therefore
similarly be improved by the addition of symptoms such as
these.
Those who wish to use the QL Index as a predictor of life
expectancy will need to decide which cut-off point on the QL
Index is most useful. The decision will depend upon the
implications of mis-classification. It might be preferable to
treat patients who live longer than 6 months as if they were
going to die within this period than to risk doing the reverse.
Such patients might benefit if, for instance, they are referred
to a hospice or home care team earlier and therefore have a
longer period to develop good communications with the staff
(Evans & McCarthy, 1984). In this case a cut-off point which
provided good sensitivity would be selected in order to
reduce the likelihood of appropriate terminal care being pro-
vided too late. Alternatively, it may be decided that it is
undesirable to erroneously label a patient as likely to die
within 6 months who will in fact live for longer. In this case
it would be advisable to adopt a cut-off point on the QL
Index which has high specificity. Whether the QL Index is
felt to have value in reducing prognostic uncertainty in ter-
minal care and, if so, which cut-off should be adopted, will
therefore depend partly on whether it is considered better to
include everyone with any likelihood of dying within 6
months or to include only those who are almost certain to
die within this period.
This issue is of more than theoretical interest and has
important implications in the light of current trends in health
care provision. In the USA ifpatients are classified as having
a life expectancy of less than 6 months but then live longerSPITZER QUALITY OF LIFE INDEX 699
than this the cost of their hospice care may not continue to
be re-imbursed by Medicare. Such patients could prove
expensive to hospice programmes. If patients who die within
6 months are wrongly classified as being likely to live longer
than this they may be denied entry to a hospice programme
which may have been beneficial. Pearlman (1988) has dis-
cussed this dilemma and argues that those concerned with
terminal care should determine acceptable error rates before
deciding how to assess prognosis.
Accurate prognostic information is important to those
planning and providing services as well as to clinicians con-
cerned with individual patients. It has already been noted
that the proportion of patients estimated by medical and
nursing staff as being likely to die within a year is very close
to the proportion who actually die in this period. The addi-
tion of information from the QL Index, such as the propor-
tion of these patients who have very low scores and are
therefore likely to die in the near future, may further improve
the ability to predict group survival rates. This information
would be of use to those planning services who require
information on levels of need in a population.
The QL Index is already regarded as a valuable summary
measure of quality of life in cancer patients (Clark & Fallow-
field, 1986). The results presented here suggest that it may
also be of some use in reducing prognostic uncertainty in
terminal care.
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